JP2022545019A5 - - Google Patents

Info

Publication number
JP2022545019A5
JP2022545019A5 JP2022511322A JP2022511322A JP2022545019A5 JP 2022545019 A5 JP2022545019 A5 JP 2022545019A5 JP 2022511322 A JP2022511322 A JP 2022511322A JP 2022511322 A JP2022511322 A JP 2022511322A JP 2022545019 A5 JP2022545019 A5 JP 2022545019A5
Authority
JP
Japan
Prior art keywords
methyl
dihydrothieno
cyclopenta
pyrazole
indazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022511322A
Other languages
English (en)
Japanese (ja)
Other versions
JP7651557B2 (ja
JP2022545019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/047552 external-priority patent/WO2021041276A1/en
Publication of JP2022545019A publication Critical patent/JP2022545019A/ja
Publication of JP2022545019A5 publication Critical patent/JP2022545019A5/ja
Application granted granted Critical
Publication of JP7651557B2 publication Critical patent/JP7651557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022511322A 2019-08-23 2020-08-22 Iii型受容体チロシンキナーゼ阻害剤としてのヘテロ環式ピラゾール誘導体 Active JP7651557B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962891097P 2019-08-23 2019-08-23
US62/891,097 2019-08-23
PCT/US2020/047552 WO2021041276A1 (en) 2019-08-23 2020-08-22 Heterocyclic pyrazole derivatives as type iii receptor tyrosine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2022545019A JP2022545019A (ja) 2022-10-24
JP2022545019A5 true JP2022545019A5 (cg-RX-API-DMAC7.html) 2023-08-18
JP7651557B2 JP7651557B2 (ja) 2025-03-26

Family

ID=74685735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022511322A Active JP7651557B2 (ja) 2019-08-23 2020-08-22 Iii型受容体チロシンキナーゼ阻害剤としてのヘテロ環式ピラゾール誘導体

Country Status (11)

Country Link
US (1) US12448394B2 (cg-RX-API-DMAC7.html)
EP (1) EP4017853A4 (cg-RX-API-DMAC7.html)
JP (1) JP7651557B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220051365A (cg-RX-API-DMAC7.html)
CN (1) CN114502553B (cg-RX-API-DMAC7.html)
AU (1) AU2020337883B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022003383A2 (cg-RX-API-DMAC7.html)
CA (1) CA3151821A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022002062A (cg-RX-API-DMAC7.html)
TW (1) TWI759829B (cg-RX-API-DMAC7.html)
WO (1) WO2021041276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113278010A (zh) * 2021-06-01 2021-08-20 中国科学院上海有机化学研究所 一类蛋白激酶降解剂及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003234567A1 (en) * 2002-05-15 2003-12-02 Janssen Pharmaceutica N.V. N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
RU2425677C2 (ru) 2005-01-21 2011-08-10 Астекс Терапьютикс Лимитед Соединения, предназначенные для использования в фармацевтике
EP1845974A1 (en) * 2005-01-21 2007-10-24 Astex Therapeutics Limited Pharmaceutical compounds
BRPI0618011A2 (pt) * 2005-10-28 2011-08-16 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente
WO2008045627A2 (en) 2006-10-06 2008-04-17 Irm Llc Protein kinase inhibitors and methods for using thereof
CA2686378C (en) * 2007-05-04 2012-07-24 Irm Llc Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
CA2780892C (en) * 2009-11-13 2017-02-14 Genosco Kinase inhibitors
GB201007286D0 (en) * 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
UY33801A (es) 2010-12-13 2013-06-28 Array Biopharma Inc COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III
WO2013142382A1 (en) * 2012-03-22 2013-09-26 Genosco Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
GB201205669D0 (en) * 2012-03-30 2012-05-16 Agency Science Tech & Res Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof
US8853207B2 (en) * 2012-04-12 2014-10-07 Development Center For Biotechnology Heterocyclic pyrazole compounds, method for preparing the same and use thereof
US9938273B2 (en) 2015-12-07 2018-04-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
CN119792569A (zh) 2018-01-10 2025-04-11 财团法人生物技术开发中心 抗体protac偶联物

Similar Documents

Publication Publication Date Title
JP2022531801A5 (cg-RX-API-DMAC7.html)
JP2022531932A5 (cg-RX-API-DMAC7.html)
RU2009125897A (ru) Ингибиторы фосфоинозитид-3-киназы и способы их применения
TWI343383B (en) Pyrazole derivatives and uses thereof
ES2665036T3 (es) Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas
AU2013207205B2 (en) 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of Hepatitis B
JP6231085B2 (ja) アミノキナゾリン誘導体及びピリドピリミジン誘導体
US9290507B2 (en) B-RAF kinase inhibitors
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
JP2010512338A5 (cg-RX-API-DMAC7.html)
JP2014531465A5 (cg-RX-API-DMAC7.html)
JP2013523884A5 (cg-RX-API-DMAC7.html)
JP2019535689A5 (cg-RX-API-DMAC7.html)
JP2013539777A5 (cg-RX-API-DMAC7.html)
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
KR20150131224A (ko) 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2016522246A5 (cg-RX-API-DMAC7.html)
EP3157521A1 (en) Substituted indazole compounds as irak4 inhibitors
JP2016523911A5 (cg-RX-API-DMAC7.html)
DK3053923T3 (en) TRIAZOLOPYRAZINE DERIVATIVES AS TYROSIN KINASE INHIBITORS
RU2009105829A (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb
CA2899968A1 (en) Substituted 2-aminopyridine protein kinase inhibitor
JP2018507235A5 (cg-RX-API-DMAC7.html)
IL274198B2 (en) Use of Nox inhibitors to treat cancer